These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 38673770)

  • 1. Roles of β-Cell Hypoxia in the Progression of Type 2 Diabetes.
    Yamagata K; Tsuyama T; Sato Y
    Int J Mol Sci; 2024 Apr; 25(8):. PubMed ID: 38673770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia causes pancreatic β-cell dysfunction and impairs insulin secretion by activating the transcriptional repressor BHLHE40.
    Tsuyama T; Sato Y; Yoshizawa T; Matsuoka T; Yamagata K
    EMBO Rep; 2023 Aug; 24(8):e56227. PubMed ID: 37341148
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Oxidative Stress and Hypoxia in Pancreatic Beta-Cell Dysfunction in Diabetes Mellitus.
    Gerber PA; Rutter GA
    Antioxid Redox Signal; 2017 Apr; 26(10):501-518. PubMed ID: 27225690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The molecular mechanisms of pancreatic β-cell glucotoxicity: recent findings and future research directions.
    Bensellam M; Laybutt DR; Jonas JC
    Mol Cell Endocrinol; 2012 Nov; 364(1-2):1-27. PubMed ID: 22885162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The pancreatic beta cells in human type 2 diabetes.
    Marchetti P; Bugliani M; Boggi U; Masini M; Marselli L
    Adv Exp Med Biol; 2012; 771():288-309. PubMed ID: 23393686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impairment of pancreatic β-cell function by chronic intermittent hypoxia.
    Wang N; Khan SA; Prabhakar NR; Nanduri J
    Exp Physiol; 2013 Sep; 98(9):1376-85. PubMed ID: 23709585
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hyperoxia reverses glucotoxicity-induced inhibition of insulin secretion in rat INS-1 β cells.
    Matsunaga T; Li S; Adachi T; Joo E; Gu N; Yamazaki H; Yasuda K; Kondoh T; Tsuda K
    Biosci Biotechnol Biochem; 2014; 78(5):843-50. PubMed ID: 25035988
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of pancreatic beta-cells: is it feasible?
    Bonora E
    Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypoxia reduces HNF4α/MODY1 protein expression in pancreatic β-cells by activating AMP-activated protein kinase.
    Sato Y; Tsuyama T; Sato C; Karim MF; Yoshizawa T; Inoue M; Yamagata K
    J Biol Chem; 2017 May; 292(21):8716-8728. PubMed ID: 28364040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Towards better understanding of the contributions of overwork and glucotoxicity to the beta-cell inadequacy of type 2 diabetes.
    Weir GC; Marselli L; Marchetti P; Katsuta H; Jung MH; Bonner-Weir S
    Diabetes Obes Metab; 2009 Nov; 11 Suppl 4():82-90. PubMed ID: 19817791
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysfunction of Persisting β Cells Is a Key Feature of Early Type 2 Diabetes Pathogenesis.
    Cohrs CM; Panzer JK; Drotar DM; Enos SJ; Kipke N; Chen C; Bozsak R; Schöniger E; Ehehalt F; Distler M; Brennand A; Bornstein SR; Weitz J; Solimena M; Speier S
    Cell Rep; 2020 Apr; 31(1):107469. PubMed ID: 32268101
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuation of glucose-induced insulin secretion by intermittent hypoxia via down-regulation of CD38.
    Ota H; Tamaki S; Itaya-Hironaka A; Yamauchi A; Sakuramoto-Tsuchida S; Morioka T; Takasawa S; Kimura H
    Life Sci; 2012 Jan; 90(5-6):206-11. PubMed ID: 22154909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Development and Analysis of Novel Therapeutic Targets to Improve Pancreatic β-Cell Function in Type 2 Diabetes].
    Kaneko YK
    Yakugaku Zasshi; 2016; 136(12):1623-1629. PubMed ID: 27904096
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypoxia-inducible factor-1 mediates pancreatic β-cell dysfunction by intermittent hypoxia.
    Wang N; Shi XF; Khan SA; Wang B; Semenza GL; Prabhakar NR; Nanduri J
    Am J Physiol Cell Physiol; 2020 Nov; 319(5):C922-C932. PubMed ID: 32936698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Does epigenetic dysregulation of pancreatic islets contribute to impaired insulin secretion and type 2 diabetes?
    Dayeh T; Ling C
    Biochem Cell Biol; 2015 Oct; 93(5):511-21. PubMed ID: 26369706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pancreatic β-cell heterogeneity in health and diabetes: classes, sources, and subtypes.
    Miranda MA; Macias-Velasco JF; Lawson HA
    Am J Physiol Endocrinol Metab; 2021 Apr; 320(4):E716-E731. PubMed ID: 33586491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activating transcription factor 3 silencing ameliorates the AMPK compensatory effects for ER stress-mediated β-cell dysfunction during the progression of type-2 diabetes.
    Kim JY; Park KJ; Kim GH; Jeong EA; Lee DY; Lee SS; Kim DJ; Roh GS; Song J; Ki SH; Kim WH
    Cell Signal; 2013 Dec; 25(12):2348-61. PubMed ID: 23916985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autophagy and pancreatic β-cells.
    Mazza S; Maffucci T
    Vitam Horm; 2014; 95():145-64. PubMed ID: 24559917
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hypoxia-inducible factor-1α mediates the expression of mature β cell-disallowed genes in hypoxia-induced β cell dedifferentiation.
    Liu N; Cai X; Liu T; Zou J; Wang L; Wang G; Liu Y; Ding X; Zhang B; Sun P; Liang R; Wang S
    Biochem Biophys Res Commun; 2020 Mar; 523(2):382-388. PubMed ID: 31866014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glucose-induced O₂ consumption activates hypoxia inducible factors 1 and 2 in rat insulin-secreting pancreatic beta-cells.
    Bensellam M; Duvillié B; Rybachuk G; Laybutt DR; Magnan C; Guiot Y; Pouysségur J; Jonas JC
    PLoS One; 2012; 7(1):e29807. PubMed ID: 22235342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.